Search

This study featured the synthesis and characterization of a highly effective AlN/g-C 3 N 4 composite photocatalyst using a combination of physical grinding and calcination methods. The composite material exhibited a unique two-dimensional/two-dimensional (2D/2D) structure, with flocculent g-C 3 N 4 uniformly coated on the surface of AlN. A series of characterization techniques including FE-SEM, TEM, XRD, FT-IR and XPS committed the successful formation of the AlN/g-C 3 N 4 heterostructure. The AlN/g-C 3 N 4 composite demonstrates the improved catalytic efficiency compared to pure AlN, which can be evidenced by its exceptional photocatalytic degradation performance under visible-light irradiation. The AlN/g-C 3 N 4 composite materials exhibited significant degradation of (RhB) and tetracycline (TC). Especially, the 20 % AlN/g-C 3 N 4 component showed particularly remarkable adsorption and catalytic activity, with 98.4 % degradation of RhB solution in 25 min and 83.0 % degradation of TC solution in 60 min, with efficiencies about 3.9 and 6.8 times higher than that of pure g-C₃N 4 , attributed to its larger specific surface area and a smaller pore structure compared to pure g-C 3 N 4. Moreover, the AlN/g-C 3 N 4 heterojunction exhibited outstanding stability and reusability throughout four consecutive experimental cycles, highlighting its long-lasting and reliable performance. FT-IR analysis confirmed the structural stability of the composite material, and the free radical experiments revealed the dominant role of the holes (h+) free radical in the photocatalytic reaction. Additionally, UV–vis diffuse reflectance and Mott-Schottky tests supported the Z-type charge carrier transport route as the photocatalytic mechanism. Overall, the AlN/g-C 3 N 4 heterostructure have shown great potential as a highly efficient photocatalyst for pollutant degradation, due to its unique structure, high specific surface area, and effective charge carrier separation, making it a promising material for diverse environmental applications. [Display omitted] [ABSTRACT FROM AUTHOR]

Porous mullite ceramics were fabricated from an industrial grade mullite powder by gelcasting process using fly ash cenospheres ( FAC) as a pore-forming agent. The influence of content of FAC and sintering temperature on the density and strength was evaluated. The microstructure showed that FAC can act as a sintering aid and a pore-forming agent. When the sintering temperature at 1200°C, porous mullite ceramics with a relatively high porosity (48.1-72.2%), low density (0.84-1.64 g/cm3), low thermal conductivity (0.16-0.22 W/m · K), and high compressive strength (6.21-14.70 MPa) have been obtained. [ABSTRACT FROM AUTHOR]

The expression of Programmed cell Death Ligand 1 (PD-L1) is observed in many malignant tumors and is associated with poor prognosis including Gastric Cancer (GC). The relationship between PD-L1 expression and prognosis, however, is controversial in GC. This paper purports to use a meta-analysis to investigate the relationship between PD-L1 expression and prognosis in GC. For this study, the following databases were searched for articles published from June 2003 until February 2017: PubMed, EBSCO, Web of Science and Cochrane Library. The baseline information extracted were: authors, year of publication, country where the study was performed, study design, sample size, follow-up time, baseline characteristics of the study population, pathologic data, overall survival (OS). A total of 15 eligible studies covering 3291 patients were selected for a meta-analysis based on specified inclusion and exclusion criteria. The analysis showed that the expression level of PD-L1 was associated with the overall survival in GC (Hazard Ratio, HR = 1.46, 95%CI = 1.08–1.98, P = 0.01, random-effect). In addition to the above, subgroup analysis showed that GC patients with deeper tumor infiltration, positive lymph-node metastasis, positive venous invasion, Epstein-Barr virus infection positive (EBV+), Microsatellite Instability (MSI) are more likely to expression PD-L1. The results of this meta-analysis suggest that GC patients, specifically EBV+ and MSI, may be prime candidates for PD-1 directed therapy. These findings support anti-PD-L1/PD-1 antibodies as a kind of immunotherapy which is promising for GC. [ABSTRACT FROM AUTHOR]